Subscribe

Physitrack PLC (PTRK.ST)

SEK7.62 +0.02 (+0.26%)
GB STO Healthcare Medical - Healthcare Information Services
Address Bastion House EC2Y 5DN
London, GB
CEO Henrik Molin
Website physitrack.com
IPO 2021-06-18
ISIN GB00BK80TJ35

Explore sections of this company profile

Description

Physitrack PLC operates globally as a digital healthcare innovator. The company delivers a proprietary cloud-based Software-as-a-Service (SaaS) platform, utilized by a diverse range of healthcare providers, from individual practitioners to large organizations, to completely digitalize the patient journey—from their initial contact through ongoing interactions and tracking of progress. Additionally, Physitrack offers virtual care solutions that address three key areas for patients and insurance plan members: preventive and wellness support, care for acute and chronic conditions, and surgical recovery. These virtual care services are supplied to healthcare enterprises such as private and public hospitals, clinics, and other health businesses. Founded in 2012, the company was formerly known as Physitrack Limited before rebranding to Physitrack PLC in May 2021 and is based in London, United Kingdom.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
SEK7.62 +0.02 (+0.26%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
37.0K
Beta
0.57
Float Shares
4.41M
Free Float %
27.1%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-2.57% -4.53% -12.47% -28.15% -43.85% -42.36% -41.69% -61.91% -83.70% -83.70% -83.70%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
7.62
DCF (Levered) 0.42 -94.5%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM)
Rating 2026-05 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
0.33
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Medical - Healthcare Information Services: +14.2%
    -14.9% Q1'26: -10.9% (vs Q1'25)
  • ✗
    EPS growth Medical - Healthcare Information Services: +43.1%
    -7.5% Q1'26: +107.0% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%
    +9.5% Q1'26: +19.8% (vs Q1'25)
  • ✗
    EBIT margin Medical - Healthcare Information Services: +8.8%
    +3.8% Q1'26: +7.7% (vs Q1'25)
  • ✗
    ROIC Medical - Healthcare Information Services: +5.2%
    +3.9% Q1'26: +5.6% (vs Q1'25)
  • ✓
    Share dilution Medical - Healthcare Information Services: -0.1%
    +0.0% ★ Q1'26: +0.0% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×
    7.58× Q1'26: 0.93× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.59) × ERP
WACC = 74% × Ke + 26% × Kd (13.5%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Current price: 7.62
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
1 Rev. Ana.
1 EPS Ana. 		Dec 2027
1 Rev. Ana.
1 EPS Ana. 		Dec 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
12.51M
est: 12.70M (-1.5%)
15.18M
est: 1.38M (+1,000.5%)
16.18M
est: 15.98M (+1.2%)
13.77M
est: 13.49M (+2.1%)
13.67M
13.67M – 13.67M
+1.4% YoY
15.65M
15.65M – 15.65M
+14.5% YoY
17.83M
17.83M – 17.83M
+13.9% YoY
EBITDA
2.57M
est: 2.43M (+6.0%)
7.09M
est: 197.9K (+3,480.7%)
-2.09M
est: 2.29M (-190.9%)
518.1K
est: 1.94M (-73.2%)
1.96M
1.96M – 1.96M
+1.4% YoY
2.25M
2.25M – 2.25M
+14.5% YoY
2.56M
2.56M – 2.56M
+13.9% YoY
EBIT
137.8K
est: 215.7K (-36.1%)
3.47M
est: 1.9K (+183,168.9%)
-6.50M
est: 21.9K (-29,774.5%)
518.1K
est: 18.5K (+2,701.1%)
18.8K
18.8K – 18.8K
+1.4% YoY
21.5K
21.5K – 21.5K
+14.5% YoY
24.5K
24.5K – 24.5K
+13.9% YoY
Net Income
92.3K
est: 974.0K (-90.5%)
3.20M
-6.45M
est: 489.2K (-1,419.4%)
-6.92M
est: 1.69M (-510.7%)
1.60M
1.60M – 1.60M
-5.0% YoY
1.62M
1.62M – 1.62M
+1.2% YoY
1.62M
1.62M – 1.62M
+0.0% YoY
SGA
12.40M
est: 5.99M (+107.1%)
—
est: 462.6K (-100.0%)
—
est: 5.36M (-100.0%)
—
est: 4.52M (-100.0%)
4.59M
4.59M – 4.59M
+1.4% YoY
5.25M
5.25M – 5.25M
+14.5% YoY
5.98M
5.98M – 5.98M
+13.9% YoY
EPS
0.01
est: 0.06 (-83.3%)
0.20
-0.41
est: 0.03 (-1,462.8%)
-0.43
est: 0.10 (-514.8%)
0.10
0.10 – 0.10
-5.0% YoY
0.10
0.10 – 0.10
+1.2% YoY
0.10
0.10 – 0.10
+0.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-05-28 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-05-27 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-05-26 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-05-25 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-05-22 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-05-21 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-05-20 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-05-19 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-05-18 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-05-15 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-05-13 C 2/5 2/5 1/5 1/5 2/5 1/5 4/5
2026-05-12 C 2/5 2/5 1/5 1/5 2/5 1/5 4/5
2026-05-11 C 2/5 2/5 1/5 1/5 2/5 1/5 4/5
2026-05-08 C 2/5 2/5 1/5 1/5 2/5 1/5 4/5
2026-05-07 C 2/5 2/5 1/5 1/5 2/5 1/5 4/5
2026-05-06 C 2/5 2/5 1/5 1/5 2/5 1/5 4/5
2026-05-05 C 2/5 2/5 1/5 1/5 2/5 1/5 4/5
2026-05-04 C 2/5 2/5 1/5 1/5 2/5 1/5 4/5
2026-04-30 C 2/5 2/5 1/5 1/5 1/5 1/5 4/5
2026-04-29 C 2/5 2/5 1/5 1/5 1/5 1/5 4/5
2026-04-28 C 2/5 2/5 1/5 1/5 1/5 1/5 4/5
2026-04-27 C 2/5 2/5 1/5 1/5 1/5 1/5 4/5
2026-04-24 C- 1/5 2/5 1/5 1/5 1/5 1/5 3/5
2026-04-23 C 2/5 3/5 1/5 1/5 1/5 1/5 3/5
2026-04-22 C 2/5 3/5 1/5 1/5 1/5 1/5 3/5
2026-04-21 C 2/5 3/5 1/5 1/5 1/5 1/5 3/5
2026-04-20 C 2/5 3/5 1/5 1/5 1/5 1/5 3/5
2026-04-17 C 2/5 3/5 1/5 1/5 1/5 1/5 3/5
2026-04-16 C 2/5 3/5 1/5 1/5 1/5 1/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
2.38M
OE per share TTM
0.15
Owner's Yield
1.93%
Maintenance CapEx ratio
50.34%
Maint CapEx / Avg PPE
0.6%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
6.4K
Shares Outstanding
16.26M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Henrik Molin Co-Founder, Chief Executive Officer & Executive Director 312.5K male
Jack Goodwin Chief Operating Officer 161.7K male
Matthew Poulter Chief Financial Officer 136.5K male
Kevin Kaminyar Head of Marketing — male
Michal Wegrzyn Head of Engineering — male
Tomasz Witkowski Head of Customer Support — male
Yanni Metaxas Head of Sales for North America — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Healthcare Information Services